Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 30, 2026
Procter & Gamble (PG) Delivers Mixed Q4 Results as Shares Decline 3-4%

Procter & Gamble (PG) Delivers Mixed Q4 Results as Shares Decline 3-4%

Key Takeaways

  • Revenue fell short of expectations: Q4 FY2026 net sales reached $21.2 billion, up 2% year-over-year but missing the consensus estimate of approximately $21.38 billion.
  • Core EPS narrowly beat estimates: Adjusted core earnings per share (EPS) came in at $1.43, edging past the analyst consensus of $1.42, though declining 3% from $1.48 in the prior-year quarter.
  • Organic sales were flat: Organic sales growth — a key metric that strips out currency fluctuations, acquisitions, and divestitures — registered 0%, with volume, pricing, and mix all neutral in the quarter.
  • Margins under pressure: Core operating margin contracted 130 basis points year-over-year, marking the third consecutive quarter of margin compression, driven by higher SG&A (selling, general and administrative) costs and commodity inflation.
  • FY2027 guidance disappointed: Management issued fiscal 2027 core EPS guidance of $6.89 to $7.11, with a midpoint of $7.00, slightly below consensus, while projecting total sales growth of just 1% to 3%.
  • Shares declined sharply: PG stock fell approximately 3% to 4% in intraday trading following the release, reflecting investor concern over the soft revenue print and cautious forward outlook.

Earnings Context and Why It Matters

Procter & Gamble’s fourth-quarter fiscal 2026 results, reported on July 29, 2026, provide a useful window into the consumer staples sector during a period of ongoing macroeconomic pressure. As one of the largest consumer packaged goods companies—with well-known brands such as Tide, Pampers, Gillette, and Crest—PG serves as a useful indicator of household spending and broader consumer trends. This report is particularly relevant given persistent inflation, elevated commodity costs partly linked to geopolitical tensions, and more price-sensitive consumers who are shifting toward value options in some categories. With full-year organic sales growth slowing to 1% (down from 2% in FY2025 and 4% in FY2024), investors are watching closely to see whether PG can restore volume growth while maintaining profitability.

Reported Results

For the fourth quarter of fiscal 2026 ended June 30, 2026, Procter & Gamble reported net sales of $21.2 billion, a 2% increase from $20.9 billion in the prior-year period. The top line nonetheless came in below the analyst consensus of approximately $21.38 billion. Foreign exchange added about one percentage point to growth, while volume, pricing, and mix were neutral overall, leaving organic sales flat year-over-year.

GAAP diluted net EPS declined 15% to $1.26, affected by lower gross margins and higher SG&A expenses. Core EPS, which excludes certain one-time items, fell 3% to $1.43 but still edged past the consensus of $1.42. On a currency-neutral basis, core EPS declined 5% from the prior year. Net earnings totaled $3.04 billion, down 16% from $3.62 billion a year earlier.

Segment results were mixed. Beauty delivered 4% organic sales growth, supported by mid-single-digit gains in hair care and skin and personal care. Grooming and Fabric & Home Care were flat organically, Health Care declined 1%, and Baby, Feminine & Family Care posted a 2% organic sales drop as both volume and pricing weakened. I also checked this using Tickeron’s AI Screener to see how PG stacks up against peers in the sector.

For the full fiscal year 2026, PG reported net sales of $87.0 billion (up 3%) and core EPS of $6.89 (up 1%). Operating cash flow reached $19.6 billion, and the company returned more than $15 billion to shareholders through $10.2 billion in dividends and $5.0 billion in share repurchases. The April 2026 dividend increase marked the 70th consecutive year of dividend growth.

Market Reaction and Investor Sentiment

Investors reacted negatively to the results, with PG shares declining roughly 3% to 4% in Wednesday trading. Although the small core EPS beat provided a modest positive, the revenue miss and cautious fiscal 2027 outlook weighed more heavily on sentiment. Management highlighted roughly $1 billion in after-tax headwinds from higher raw material, energy, and transportation costs, partly tied to Middle East developments and oil prices near $90 per barrel. With organic sales stalled and three of five segments showing flat or negative growth, the market focused on the durability of top-line momentum and margin resilience. From what I see, the reaction underscores that investors are prioritizing sustained revenue growth over a one-penny EPS beat in the current environment.

Forward Outlook and Key Factors to Monitor

Looking ahead to fiscal 2027, Procter & Gamble expects organic sales growth of 1% to 3% and core EPS between $6.89 and $7.11, implying flat to 3% growth versus fiscal 2026. Management noted that the first quarter is likely to be the most difficult, with EPS expected to decline at least 5% year-over-year before conditions improve later in the year.

Key variables include the path of commodity costs, especially crude oil, which affects raw materials, energy, and transportation. The company is budgeting for approximately $1 billion in after-tax commodity headwinds, or about $0.56 per share—an 8% drag on core EPS growth. Consumer behavior will also matter, particularly as lower-income households continue to seek value and private-label options. The Beauty segment has held up well, but softness in Grooming, Health Care, and Family Care deserves attention.

Productivity efforts remain central. PG achieved 340 basis points of productivity savings in fiscal 2026 and plans to fund reinvestments through further efficiency gains. E-commerce, which grew 6% and now accounts for 20% of sales, is another area of focus. I’m watching this closely as digital channels continue to evolve. Investors should track quarterly organic sales trends, segment volume performance, and margin trends throughout the year.

Using Tickeron’s AI Tools in My Research

When evaluating earnings reports like this one, I find it helpful to run quick comparisons with Tickeron’s AI Screener. The tool lets me filter stocks by industry, market cap, technical signals, and other criteria to see how PG and similar names are performing relative to peers. It saves time and surfaces ideas I might otherwise miss during earnings season.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: PG

PG in +1.00% Uptrend, rising for three consecutive days on July 28, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where PG advanced for three days, in of 351 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 50-day moving average for PG moved above the 200-day moving average on July 27, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

The Aroon Indicator entered an Uptrend today. In of 266 cases where PG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 65 cases where PG's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on July 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PG as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for PG turned negative on July 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

PG moved below its 50-day moving average on July 29, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PG declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.329) is normal, around the industry mean (28.056). P/E Ratio (21.360) is within average values for comparable stocks, (57.644). Projected Growth (PEG Ratio) (4.104) is also within normal values, averaging (3.014). Dividend Yield (0.029) settles around the average of (0.034) among similar stocks. P/S Ratio (4.095) is also within normal values, averaging (2.359).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PG’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Procter & Gamble Company (NYSE:PG), Colgate-Palmolive Company (NYSE:CL).

Industry description

Household/Personal Care companies sell products for home cleaning and/or personal hygiene and grooming purposes. Products of this industry include detergents, shampoos, soaps, cosmetics, fabric conditioners and infant care fragrances. Procter & Gamble, Unilever, Estee Lauder and Colgate-Palmolive are some of the biggest names in the business. A lot of the products become a necessary part of people’s daily routine, and therefore the industry is relatively less vulnerable to macroeconomic downturns. At the same time, product quality, consumer safety, and ease of use are extremely critical factors for a company to survive competition and earn recognition in this industry.

Market Cap

The average market capitalization across the Household/Personal Care Industry is 23.22B. The market cap for tickers in the group ranges from 81.32K to 340.21B. PG holds the highest valuation in this group at 340.21B. The lowest valued company is QNTA at 81.32K.

High and low price notable news

The average weekly price growth across all stocks in the Household/Personal Care Industry was 0%. For the same Industry, the average monthly price growth was 3%, and the average quarterly price growth was -5%. ACU experienced the highest price growth at 31%, while BYAH experienced the biggest fall at -17%.

Volume

The average weekly volume growth across all stocks in the Household/Personal Care Industry was 76%. For the same stocks of the Industry, the average monthly volume growth was -4% and the average quarterly volume growth was -24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 54
Price Growth Rating: 52
SMR Rating: 70
Profit Risk Rating: 90
Seasonality Score: 1 (-100 ... +100)
View a ticker or compare two or three
PG
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of branded consumer packaged goods

Industry HouseholdPersonalCare

Profile
Details
Industry
Household Or Personal Care
Address
One Procter and Gamble Plaza
Phone
+1 513 983-1100
Employees
107000
Web
https://www.pginvestor.com
Interact to see
Advertisement
The Travelers Companies, Inc.(TRV), a major player in the property and casualty insurance market, reported fourth-quarter 2025 results on January 21, 2026, closing out a year marked by underwriting discipline despite volatile weather activity and pricing pressures. The results underscore Travelers’ ability to generate strong profitability while navigating challenges in personal insurance lines and heightened catastrophe risk.
FingerMotion, Inc. (NASDAQ: FNGR) reported fiscal third-quarter 2026 results on January 15, 2026, triggering a sharp selloff as investors reacted to a steep revenue decline and widening losses. Shares fell roughly 32% following the release after the mobile services provider disclosed a 32% year-over-year drop in revenue and a net loss of $1.67 million for the quarter ended November 30, 2025.
CSX (NASDAQ: CSX) reports Q4 2025 earnings after market close on January 22, 2026, with consensus EPS ~$0.42 and revenue ~$3.57 billion. Union Pacific (NYSE: UNP) follows on January 27, with EPS expected near $2.89 and revenue around $6.15 billion. Norfolk Southern (NYSE: NSC) closes the week on January 29, with consensus EPS ~$2.77.
The SPDR S&P Aerospace & Defense ETF (XAR) has surged to a new 52-week high above $281 this week, climbing 21% month-to-date and 20% year-to-date through January 2026. The rally, driven by robust sector momentum and a clean technical breakout, is outpacing broader indices like the S&P 500. XAR’s equal-weighted structure amplifies gains from top aerospace and defense holdings in missiles, aircraft, and space systems, attracting significant trader and institutional attention amid heightened geopolitical tensions.
The iShares U.S. Aerospace & Defense ETF (ITA) continues to attract trader attention, building on a remarkable 47.7% gain in 2025 amid rising defense budgets and heightened global security concerns. The ETF is approaching all-time highs, with top holdings such as GE Aerospace and RTX Corporation driving the rally. Traders are adding positions on dips while monitoring confirmation above key resistance levels near recent peaks, anticipating a potential technical breakout.
Chevron’s upcoming Q4 report highlights its first full quarters integrating Hess, following record Q3 production of 4.1 million barrels of oil equivalent per day (MMboe/d). Comparing CVX with ExxonMobil and Shell provides insight into how each supermajor is navigating a volatile oil market with prices hovering below $60 per barrel.
SoFi Technologies is set to report Q4 and full-year 2025 earnings on January 30, 2026, closing out a pivotal year for the digital finance platform. With its fiscal year ending December 31, the report follows a strong Q3 that featured record net revenue of $962 million and member growth to 12.6 million, a 35% year-over-year increase.
ASML reported Q4 2025 net sales of $9.7 billion, gross margin of 52.2%, net income of $2.8 billion, and record net bookings of $13.2 billion, including $7.4 billion in EUV orders.
IDEXX Laboratories (IDXX) reports Q4 2025 earnings on February 2, 2026, with analysts expecting continued strength in recurring revenue from companion animal diagnostics. Danaher (DHR) reports on January 28, while Thermo Fisher Scientific (TMO) follows in early February, with both facing low-single-digit core growth expectations across life sciences and diagnostics.
NIO Inc. (NIO) produced its one-millionth vehicle this week at its Hefei facility, closing out a record 2025 delivery total of 326,028 units, up 46.9% year over year. The milestone, announced January 6, reflects accelerating demand for core models such as the ES8 SUV and newer brands ONVO and Firefly.
Faraday Future Intelligent Electric Inc. (FFAI) shares traded near $1.02 this week following announcements of a non-binding $10 million stock purchase term sheet with AIxCrypto (AIxC) and preparations for a Stockholders’ Day on January 7, 2026. Trading volume spiked amid broader EV volatility, highlighting investor attention on FFAI’s pivot toward AI-enhanced mobility and robotics.
BTQ Technologies Corp. (BTQ), formerly BTQQF, launched the Bitcoin Quantum testnet this week—the first quantum-safe Bitcoin fork, 17 years after Bitcoin’s genesis block. The move coincided with inclusion in the $524.5 million VanEck Quantum Computing UCITS ETF, boosting European investor visibility.
VEU targets large- and mid-cap ex-U.S. stocks with ~3,800 holdings. VXUS offers broad all-cap exposure, including ~8,600 stocks across small-, mid-, and large-cap companies.
Apple (AAPL) reports Q1 FY2026 earnings on January 29, with consensus revenue at $138.5B and EPS at $2.67, supported by strong demand for iPhone 17 models, higher average selling prices, and continued Services growth. Microsoft (MSFT) reports Q2 FY2026 on January 28, expecting $80.3B revenue and $3.91 EPS, driven by Azure AI adoption and enterprise cloud expansion, though elevated capex spending (~$35B/quarter) remains under scrutiny.
Visa Inc. (V), the global payments network leader, reports Q1 FY2026 earnings on January 29, 2026, for the period ending December 31, 2025. This marks the start of FY2026 following a strong FY2025, where net revenue reached $40 billion (+11%) and EPS climbed to $11.47 (+14%). Investors are watching closely for insights into consumer spending, cross-border travel recovery, and digital payment adoption.
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.